Efficacy of nicotineless non-pharmacologic alternative tool for smoking cessation program using varenicline

K. Yoshinoya, M. Kadoya, Y. Kasamatsu (Osaka, Japan)

Source: Annual Congress 2012 - Tobacco cessation
Session: Tobacco cessation
Session type: Thematic Poster Session
Number: 4037
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Yoshinoya, M. Kadoya, Y. Kasamatsu (Osaka, Japan). Efficacy of nicotineless non-pharmacologic alternative tool for smoking cessation program using varenicline. Eur Respir J 2012; 40: Suppl. 56, 4037

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of a multicomponent smoking cessation program
Source: Annual Congress 2008 - Smoking cessation and new tobacco uses
Year: 2008

Effectiveness of varenicline treatment in a smoking cessation clinic
Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation
Year: 2009


Evidence of the effectiveness and safety of first-line smoking cessation pharmacotherapy
Source: Eur Respir Monogr 2021; 90: 97-117
Year: 2021


Effectiveness and cost-effectiveness of smoking cessation interventions
Source: International Congress 2015 – New advances in smoking cessation interventions
Year: 2015



Efficacy of bupropion therapy in smoking cessation
Source: Eur Respir J 2004; 24: Suppl. 48, 153s
Year: 2004

Is NRT in combination with other drugs more effective than NRT alone in smoking cessation?
Source: ISSN=ISSN 1810-6838, ISBN=, page=246
Year: 2005

A pharmacological with nicotine or bupropion versus an integrated pharmacological and psychological program for smoking cessation
Source: Eur Respir J 2002; 20: Suppl. 38, 579s
Year: 2002

Evaluation of prolonged bupropion treatment as an aid in smoking cessation
Source: Eur Respir J 2002; 20: Suppl. 38, 611s
Year: 2002

Smoking cessation in COPD, modelling the cost effectiveness of minimal counseling or intensive counseling plus bupropion
Source: Eur Respir J 2004; 24: Suppl. 48, 463s
Year: 2004

Bupropion treatment and cognitive behavioural therapy in a smoking cessation program
Source: Eur Respir J 2001; 18: Suppl. 33, 12s
Year: 2001

Effectiveness of treatment with bupropion HCL, NRTs and combination in smoking cessation
Source: Eur Respir J 2004; 24: Suppl. 48, 156s
Year: 2004

Cost-effectiveness of varenicline for smoking cessation in the Netherlands
Source: Eur Respir J 2007; 30: Suppl. 51, 247s
Year: 2007

Comparison of efficacy of varenicline and nortriptyline– Short-term smoking cessation in outpatient setting
Source: International Congress 2016 – Emerging issues in smoking cessation and tobacco products
Year: 2016


Cost-effectiveness of 5 smoking cessation interventions
Source: Eur Respir J 2004; 24: Suppl. 48, 463s
Year: 2004

Effectiveness of a personalized smoking cessation counseling program in patients with oral cancer: preliminary results
Source: International Congress 2017 – Smoking cessation
Year: 2017


Cytisine is an effective smoking cessation medication: more evidence now than ever before
Source: International Congress 2017 – Smoking cessation treatment and e-cigarettes
Year: 2017

Efficacy of Zyban as smoking cessation aid for medical staff
Source: Eur Respir J 2001; 18: Suppl. 33, 447s
Year: 2001

Pharmacological treatment for smoking cessation
Source: Eur Respir Mon; 2008: 42: 74–97
Year: 2008

Are e-cigarettes effective and safe for smoking cessation?
Source: International Congress 2014 – PG14 Smoking cessation in patients with pulmonary disorders
Year: 2014